Clinical Trial Update: Pharmacokinetics of Levodopa/Carbidopa Infusion With and Without Oral Catechol-O-methyl Transferase (COMT) Inhibitors [Phase 4]

View source ↗

Summary

Phase 4 pharmacokinetic study evaluating levodopa/carbidopa infusion with and without oral COMT inhibitors in Parkinson disease, and the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Entacapone (Entacapone)
• Tolcapone (tolcapone)
• levodopa/carbidopa infusion (levodopa/carbidopa)

Snippet

Sponsor: Uppsala University | Conditions: Parkinson Disease | Phase 4 | Status: COMPLETED